You searched for 1 - Page 24 of 88

March 25, 2024

C-Path to Spearhead New Task Force Dedicated to Accelerating Drug Development for Progressive Supranuclear Palsy

Critical Path Institute (C-Path) today announced the formation of a new task force...

March 8, 2024

In this webinar from The Critical Path Institute’s Rare and Orphan Disease Program CP-RND consortium, members discuss...

March 15, 2024

TUCSON, Ariz., March 15, 2024 — Critical Path Institute’s (C-Path) CURE Drug Repurposing Collaboratory (CDRC), a leading advoc

March 5, 2024

Critical Path Institute proudly recruits elite talent from across the globe, supporting remote work and a healthy work-life....

February 15, 2024

Disease progression modeling synthesizes statistics with disease knowledge and data to inform predictions and understanding of dis

February 15, 2024

Critical Path Institute (C-Path) today officially launched its newly revamped website, designed to further enhance collab...

February 1, 2024

n a significant step to enhance research efforts for SCN2A-related autism and epilepsy, Critical Path Institute (C-Path) and Famil

January 30, 2024

TRxA’s focus is translating early-stage novel therapeutics into Investigational New Drug (IND) supporting data packages that...

January 30, 2024

C-Path's Patient-Reported Outcome (PRO) Consortium today announced...

January 25, 2024

Critical Path Institute (C-Path) today announced the promotion of Cécile Ollivier, M.S., from Managing Director, Europe to...